statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter...

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Fortress Biotech reports FY23 EPS ($8.47) vs. ($15.97) last year

Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application...

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Planning for proof-of concept Phase 1 investigator-sponsored clinical trial evaluating MB-106 CD20-targeted CAR T-cell therapy in autoimmune diseases is underway and expected to initiate in the...

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) ( Avenue or the Company ), a specialty pharmaceutical company focused on the development and commercialization...

Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ( Checkpoint ) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced...

Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 Achieved $15.6 million in operating cost...

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Research analysts at Alliance Global Partners assumed coverage on shares of Fortress Biotech (NASDAQ:FBIO  Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The firm...

Fortress Biotech (NASDAQ:FBIO) Receives New Coverage from Analysts at Alliance Global Partners

Fortress Biotech initiated with bullish view at Alliance Global Partners, here's why

Fortress Biotech, Inc. (NASDAQ:FBIO  Get Free Report) was the recipient of a large decline in short interest in February. As of February 29th, there was short interest totalling 1,540,000...

Fortress Biotech, Inc. (NASDAQ:FBIO) Short Interest Update

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Volume	177,765.00
52-Wk High	$11.50
52-Wk Low	$1.24

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.73	--	--	N/A
Q4'23	-$1.65	-$0.78	52.58%	BEAT
Q3'23	-$3.21	-$0.94	70.68%	BEAT
Q2'23	-$3.41	-$3.60	-5.49%	MISSED
Q1'23	-$3.00	-$3.15	-5.00%	MISSED

FBIO Fortress Biotech Inc

About

Feed

News

Earnings

Fundamentals